Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
carboxymethylcellulose + glycerin + N-acetylcarnosine (Optho Pharma)
- Development stage
- Unknown
- Lead developer
- Optho Pharma
- Modality
- Small Molecules, Peptides
- Administration
- Ophthalmic
01
Overview
Lubrinac is a combination lubricant eye drop developed by Optho Pharma for the treatment of dry eye symptoms and the support of overall ocular health. The formulation combines carboxymethylcellulose sodium, glycerin, and N-acetylcarnosine. Carboxymethylcellulose and glycerin serve as demulcents and lubricants that supplement the natural tear film, providing temporary relief from burning, irritation, and discomfort associated with dry eyes. N-acetylcarnosine is a dipeptide derivative with antioxidant properties that helps protect ocular tissues from oxidative damage and is often promoted to help delay the progression of age-related cataracts.
- Brand names
- C-NacCan-CLubrinac
- Other names
- carboxymethylcellulose + glycerin + acetylcarnosinecarboxymethylcellulose sodium + glycerin + N-acetylcarnosinecarboxymethylcellulose sodium + glycerin + acetylcarnosineglycerin + carboxymethylcellulose + N-acetylcarnosineglycerin + carboxymethylcellulose sodium + N-acetylcarnosine
02
Targets
CRY (Crystallin family)
Beyond the preview
Go deeper on carboxymethylcellulose + glycerin + N-acetylcarnosine (Optho Pharma).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on carboxymethylcellulose + glycerin + N-acetylcarnosine (Optho Pharma).